Thomas Bures
Insider Reports History
- Location
- Boston, MA
- Signature
- /s/ Michael Simone, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Thomas Bures:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRUKER CORP | Chief Accounting Officer | Common Stock | 3,198 | $116,758 | $36.51 | 15 Feb 2026 | Direct |
| PIERIS PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (right to buy) | 249,080 | 24 Feb 2023 | Direct |
Insider Reports Filed by Thomas Bures
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BRKR | BRUKER CORP | 15 Feb 2026 | 1 | -$10,004 | 4 | Chief Accounting Officer | 18 Feb 2026, 16:15 |
| BRKR | BRUKER CORP | 10 Mar 2025 | 1 | +$23,698 | 4 | Chief Accounting Officer | 11 Mar 2025, 16:11 |
| BRKR | BRUKER CORP | 15 Feb 2025 | 1 | $0 | 4 | Chief Accounting Officer | 19 Feb 2025, 16:39 |
| BRKR | BRUKER CORP | 13 Jan 2025 | 0 | $0 | 3 | Chief Accounting Officer | 16 Jan 2025, 17:17 |
| PVLA | PIERIS PHARMACEUTICALS, INC. | 24 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 28 Feb 2023, 16:39 |
| PVLA | PIERIS PHARMACEUTICALS, INC. | 22 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 24 Feb 2022, 15:46 |